Sanofi

Clinical Study Results Medicines, including Rare Diseases

Important

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country. In the event that the product is described as no longer a Sanofi product, reasons could include that the product was transferred to another company.

This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

Filter by:

And

1248 result(s) found
Generic NameTrade NameCondition(s)Study CodeStudy NameAccess to Study / ProtocolAccess to Results
PAN PI3K AND MTOR INHIBITOR
Not marketed
Neoplasms
TED12471NANCT01596270Summary
PAN PI3K INHIBITOR
Not marketed
Endometrial Neoplasms
ARD11436NAEudraCT: 2009-016707-30Summary Results
PAN PI3K INHIBITOR
Not marketed
Breast Neoplasms
ARD11437NANCT01082068Summary
PAN PI3K INHIBITOR
Not marketed
Breast Neoplasms
ARD11439NAEudraCT: 2009-016862-10Summary Results
PAN PI3K INHIBITOR
Not marketed
Solid Tumors
TCD11742NANCT01357330Summary
PAN PI3K INHIBITOR
Not marketed
Solid Tumors
TED11883NANCT01392924Summary
PAN PI3K INHIBITOR
Not marketed
Neoplasms
TED12863NANCT01943838Summary
PARACETAMOL
Doliprane
Pain
PARAC_L_00859NANCT00434681Summary
PHOSPHATIDYL CHOLINE
Essentiale
Liver Disease
CHOLIL06301EPLIDNCT02517385Summary
PI3K-B INHIBITOR
Not marketed
Solid Tumors, Lymphoma
TCD12739NANCT01673737Summary

References:

* These study results were previously posted on GenzymeClinicalResearch.com
** This link replaces the same summary that was previously posted